Novosound, the Scottish company developing ultrasound technology, has appointed medical technology executive Gary Beale as executive vice chairman.
He will oversee the company’s move towards FDA clearance for its revolutionary blood pressure monitoring device.
Mr Beale was the CEO and founder of Emblation, a global medical technology company, and held senior leadership roles at Microsulis (now part of AngioDynamics) and Boston Scientific, one of the world’s top healthcare companies. Over the past two decades, he has built a track record of scaling MedTech businesses and securing significant international partnerships.
Dave Hughes, CEO and Founder of Novosound, said: “Gary brings unmatched experience in commercialising medical technology and forging strategic global alliances.”
Mr Beale said: “Novosound is one of Scotland’s most innovative companies and is entering a transformative phase.
“As we advance toward FDA clearance for our ultrasound blood pressure monitoring solution, I believe this technology will redefine global standards in health monitoring and unlock substantial commercial opportunities in the digital health space.”
#MedTech #specialist #Beale #chair #Novosound #Daily #Business